Gentagen administration skal kun overvejes for patienter hvis sera ikke viser en stigning i human antimus antistof (HAMA) i fragmenttesten.
Readministration should only be considered in patients whose sera are negative for human anti-mouse antibody (HAMA) elevation in the fragment assay.